Bayani, Suaida I.
HRN: 08-77-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2023
CEFUROXIME 1.5GM (VIAL)
04/14/2023
04/21/2023
IVT
1.5 Gms
Now Then Q 8 Hrs
Incomplete Abortion
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes